F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review, the facility failed to provide pharmaceutical services (including
procedures that assure the accurate acquiring, receiving, dispensing, and administering of all drugs and
biologicals) to meet the needs of each resident for 1 of 3 residents (Resident #1) reviewed for pharmacy
services.
LVN A administered Resident #1's insulin from a flex pen (Aspart) for diabetes at lunchtime to Resident #1,
when it was not labeled with the resident's name.
This failure could place residents at risk of inaccurate drug administration and not having appropriate
therapeutic effects.
The findings included:
Record review of Resident #1's face sheet, dated 06/03/2025, revealed she was a [AGE] year-old female
who was initially admitted to the facility on [DATE] and readmitted on [DATE]. Her diagnoses included:
cerebral palsy (a group of neurological disorders that affect movement, balance and posture), type 2
diabetes mellitus (the most common form of diabetes characterized by the body's inability to properly use
insulin, leading to high sugar levels), mild intellectual disabilities (deficits in intellectual functions pertaining
to abstract/theoretical thinking), anxiety (a feeling of worry, unease, or nervousness, often accompanied by
physical symptoms like a racing heart or rapid breathing and need for assistance with personal care.
Record review of Resident #1's Annual MDS assessment, dated 05/04/2025, revealed the resident rarely or
never understood others and could rarely or never understand. She was not a candidate for a BIMS which
indicated she was severely cognitively impaired. She was dependent on staff for her ADLs, and she
received insulin injections daily.
Record review of Resident #1's physician's order, dated 12/27/2024, revealed the resident had the order of
Fiasp (brand name) Pen Fill Subcutaneous Solution Cartridge 100 UNIT/ML (Insulin Aspart (with
Niacinamide, a form of Vitamin B3) Inject as per sliding scale: if 150 - 200 = 2; 201 - 250 = 4; 251 - 300 = 6;
301 - 350 = 8; 351 - 400 = 10, subcutaneously with meals for DM If greater than 401notify MD Phone Active
03/25/2025.
Record review of Resident #1's MAR, dated from 06/01/2025 to 06/30/2025, revealed Resident #1 was
receiving Fiasp Pen Fill subcutaneous Solution Pen Injector 100 unit/ml (insulin Aspart) inject as per sliding
scale.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 4
Event ID:
455732
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
455732
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/04/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Kirkwood Manor
2590 Loop 337 N
New Braunfels, TX 78130
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Observation on 06/03/2025 at 12:15 p.m., revealed LVN A proceeded to administer Resident #1 her insulin.
The insulin pen was lying on a medication tray, had an open date of 05/20/25 and an expiration date. The
insulin pen which was Aspart, 100 UNITS/ML did not have Resident #1's name.
In an interview on 06/03/2025 at 12:17 p.m., with LVN A she stated she usually labels the pens with the
resident's names and did not know why the insulin pen was not labeled.
Observation on 06/03/2025 at 12:19 p.m., revealed LVN A writing with a marker, Resident #1's name on the
Aspart insulin pen.
In an interview on 06/03/2025 at 12:20 p.m., LVN A, stated she knew the Aspart insulin pen belonged to
Resident #1 because she was the only resident on the 400 Hall with that type of insulin.
Observation on 06/03/2025 at 12:24 p.m., LVN A, proceeded to administer Resident #1 4 units of the
Aspart insulin as ordered for her blood sugar sliding scale.
In an Interview on 06/03/2025 at 12:46 p.m., the DON, stated insulin pens needed to be labeled. He said he
was not aware Resident #1's pen was not labeled. He stated Resident #1's family brought in her insulin and
the pen should not be placed on the medication cart without her name. He stated he was accountable for
the nursing care at the facility and nurses were trained on the 6 rights of medication administration. He
stated it was not acceptable to administer insulin to Resident #1 without a name on the insulin pen or
assume an unlabeled pen belonged to a specific resident. He stated the consequences could be cross
contamination of a blood borne pathogen. He stated the unlabeled insulin pen needed to be discarded
when LVN A found it on the cart.
Interview on 06/04/2025 at 12:50 p.m., LVN A, stated she knew not to give residents medications that was
unlabeled. She stated she was trained not to do that, and did not think about it at the time, but the
consequences could be cross contamination.
Interview on 06/04/2025 at 1:36 p.m., the ADON, stated when insulin pens arrived at the facility they were
logged in and accounted for, however, he had not encountered an unlabeled one. He stated Resident #1's
family brought the insulin in and must have missed labeling one of the pens. He stated he did not know how
it was found on a cart without a label. He stated he trained LVN A and provided a skills checklist which she
completed.
Record review of LVN A's medication administration skills checklist dated 12/12/2024 reflected
Pre-Administration, gather medication for one resident at a time while adhering to the six rights of
medication administration (drug, dose, route, time, resident and documentation), select correct drug and
compare name on medication label with the MAR.
Record review of the facility policy and procedure titled Section: Medication Administration, Subject:
Administration of Medication dated revised 07/2013 and reviewed 06/2022 reflected The seven rights of
medication administration are as follows to ensure safety and accuracy of administration, 1. Right Resident,
2. Right Time, 3. Right Medication, 4. Right Dose, 5. Right Route, 6. Right Documentation and 7. Right
Diagnosis.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
455732
If continuation sheet
Page 2 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
455732
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/04/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Kirkwood Manor
2590 Loop 337 N
New Braunfels, TX 78130
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted
professional principles; and all drugs and biologicals must be stored in locked compartments, separately
locked, compartments for controlled drugs.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observations, interviews, and record review, the facility failed to ensure all drugs and biologicals were
labeled for 1 of 3 residents (Resident #1) reviewed for medication labeling.
2. An insulin flex pen (Aspart) for diabetes had no resident's name labeled and was found on the 400-hall
medication cart on 06/03/2024 and assumed by LVN A to belong to Resident #1.
This failure could place residents at risk of use of the medication for more than one resident which could
result in contamination of a blood borne pathogen.
The findings included:
Record review of Resident #1's face sheet, dated 06/03/2025, revealed she was a [AGE] year-old female
who was initially admitted to the facility on [DATE] and readmitted on [DATE]. Her diagnoses included:
cerebral palsy (a group of neurological disorders that affect movement, balance and posture), type 2
diabetes mellitus (the most common form of diabetes characterized by the body's inability to properly use
insulin, leading to high sugar levels), mild intellectual disabilities (deficits in intellectual functions pertaining
to abstract/theoretical thinking), anxiety (a feeling of worry, unease, or nervousness, often accompanied by
physical symptoms like a racing heart or rapid breathing and need for assistance with personal care.
Record review of Resident #1's Annual MDS assessment, dated 05/04/2025, revealed the resident rarely or
never understood others and could rarely or never understand. She was not a candidate for a BIMS which
indicated she was severely cognitively impaired. She was dependent on staff for her ADLs, and she
received insulin injections daily.
Record review of Resident #1's physician's order, dated 12/27/2024, revealed the resident had the order of
Fiasp (brand name) Pen Fill Subcutaneous Solution Cartridge 100 UNIT/ML (Insulin Aspart (with
Niacinamide, a form of Vitamin B3) Inject as per sliding scale: if 150 - 200 = 2; 201 - 250 = 4; 251 - 300 = 6;
301 - 350 = 8; 351 - 400 = 10, subcutaneously with meals for DM If greater than 401notify MD Phone Active
03/25/2025.
Record review of Resident #1's MAR, dated from 06/01/2025 to 06/30/2025, revealed Resident #1 was
receiving Fiasp Pen Fill subcutaneous Solution Pen Injector 100 unit/ml (insulin Aspart) inject as per sliding
scale.
Observation on 06/03/2025 at 12:15 p.m. revealed LVN A proceeded to administer Resident #1 her PRN
insulin. The insulin pen was lying on a medication tray, had an open date of 05/20/25 and an expiration
date. The insulin pen which was Aspart, 100 UNITS/ML did not have Resident #1's name.
In an interview on 06/03/2025 at 12:17 p.m., LVN A, stated she usually labels the pens with the resident's
names and did not know why the insulin pen was not labeled.
Observation on 06/03/2025 at 12:19 p.m. revealed LVN A writing with a marker, Resident #1's name on the
Aspart insulin pen.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
455732
If continuation sheet
Page 3 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
455732
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/04/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Kirkwood Manor
2590 Loop 337 N
New Braunfels, TX 78130
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
In an interview on 06/03/2025 at 12:20 p.m., LVN A, stated she knew the Aspart insulin pen belonged to
Resident #1 because she was the only resident on the 400 Hall with that type of insulin.
Observation on 06/03/2025 at 12:24 p.m. of LVN A, she proceeded to administer Resident #1 4 units of the
Aspart insulin as ordered for her blood sugar sliding scale.
Residents Affected - Few
In an Interview on 06/03/2025 at 12:46 p.m., the DON, stated insulin pens needed to be labeled. He said he
was not aware Resident #1's pens were not labeled. He stated Resident #1's family brought in her insulin
and the pen should not be placed on the medication cart without her name. He stated the consequences
could be cross contamination of a blood borne pathogen. He stated the unlabeled insulin pen needed to be
discarded when LVN A found it on the cart.
Interview on 06/04/2025 at 12:50 p.m., LVN A, stated Resident #1's insulin pens was provided by the family
and the family member would label them. She did not know how the pen was on the medication cart without
a resident label.
Interview on 06/04/2025 at 1:36 p.m. with the ADON, he stated when insulin pens arrived at the facility they
were logged in and accounted for, however, he had not encountered an unlabeled one. He stated Resident
#1's family brought the insulin in and must have missed labeling one of the pens. He stated he did not know
how it was found on a cart without a label. He stated it would be difficult to identify whose medication it was
without a label and would not be safe.
Interview on 06/04/2025 at 2:08 p.m. with RN B, she stated an unlabeled insulin pen in the medication cart
needed to be discarded.
Record review of the facility policy and procedure titled Section: Medication Administration, Subject:
Administration of Medication dated revised 07/2013 and reviewed 06/2022 reflected The seven rights of
medication administration are as follows to ensure safety and accuracy of administration, 1. Right Resident,
2. Right Time, 3. Right Medication, 4. Right Dose, 5. Right Route, 6. Right Documentation and 7. Right
Diagnosis.
Record review of the facility policy and procedure titled Section: Care and Treatment, Subject: Medication
Access and Storage revised 05/2025 reflected: Medications labeled for individual residents are stored
separately from floor stock medications.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
455732
If continuation sheet
Page 4 of 4